tumor Press Release

  • Calling pr ads
  • Calling pr ads
Title Picture
12/12/2017 - 08:31
DARZALEX (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Johnson and Johnson's picture
Johnson and Johnson
12/11/2017 - 18:35
Early data evaluated subcutaneous delivery of DARZALEX in relapsed or refractory multiple myeloma (oral presentation;
Johnson and Johnson's picture
Johnson and Johnson
12/11/2017 - 14:37
Study identifies agent that can reverse resistance to targeted drug in some leukemia cell types
Dana Farber's picture
Dana Farber
12/11/2017 - 12:55
A new weapon against bone metastasis? Princeton lab develops antibody to fight cancer
Princeton University's picture
Princeton University
12/11/2017 - 08:48
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
Boehringer Ingelheim's picture
Boehringer-Ingelheim
12/11/2017 - 08:32
Rexahn Pharmaceuticals Presents New Preclinical Data on Supinoxin at the 2017 San Antonio Breast Cancer Symposium
Rexahn Pharmaceuticals's picture
Rexahn Pharmace...
12/11/2017 - 07:27
Roswell Park Hematology Experts Sharing New Research in ASH 2017 Podium Presentations
Roswell Park Cancer Institute's picture
Roswell Park Ca...
12/11/2017 - 07:09
Genomic Health Presents New Data Demonstrating Value of Oncotype DX to Optimize Breast Cancer Outcomes and Reduce Treatment Burden throughout Disease Continuum
Genomic's picture
Genomic
12/11/2017 - 05:49
Scientists discover possible master switch for programming cancer immunotherapy
Scripps Research's picture
Scripps Research
12/11/2017 - 00:24
Atezolizumab plus Avastin Significantly Improves Progression Free Survival Compared with Sunitinib in PD-L1 Positive Patients for the First-line Treatment of Advanced Renal Cell Carcinoma in the IMmotion151 Study
Chugai's picture
Chugai
12/10/2017 - 11:22
Sequencing offers clues to progression toward multiple myeloma
Dana Farber's picture
Dana Farber
12/10/2017 - 11:19
CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma
American Society of Hematology's picture
American Societ...
12/10/2017 - 09:49
Phase II Data Showed Genentechs Investigational Polatuzumab Vedotin Plus Bendamustine and Rituxan (BR) Increased Complete Response Rates Compared to BR Alone in Previously Treated Aggressive Lymphoma
Genentech's picture
Genentech
12/10/2017 - 06:14
Targeted Therapies Show Promise for Improving Outcomes Across a Spectrum of Hematologic Malignancies
American Society of Hematology's picture
American Societ...
12/09/2017 - 23:33
Phase III IMmotion151 Study Showed Genentechs Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Reduced the Risk of Disease Worsening or Death for the Initial Treatment of Certain People with Advanced Kidney Cancer
Genentech's picture
Genentech
12/09/2017 - 17:02
Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3-Year Follow-Up Data of IMBRUVICA (ibrutinib)
Johnson and Johnson's picture
Johnson and Johnson
12/09/2017 - 08:01
New Therapies Improve Outlook for Bleeding and Clotting Disorders
American Society of Hematology's picture
American Societ...
12/08/2017 - 17:49
Older Women with HR-positive Breast Cancer May Receive Similar Benefit from CDK 4/6 Inhibitors as Younger Women
American Association for Cancer Research's picture
American Associ...
12/08/2017 - 15:56
Myriad Genetics Presents Results From Two Important EndoPredict Studies at the 2017 San Antonio Breast Cancer Symposium
Myriad's picture
Myriad
12/08/2017 - 14:15
MMRF Precision Medicine Model Drives New Discoveries in Multiple Myeloma
Multiple Myeloma Research Foundation's picture
MMRF
12/08/2017 - 12:31
Researchers Seek Breast Cancer Biomarkers that Indicate Immunotherapy Responsiveness
Fox Chase's picture
Fox Chase
12/08/2017 - 07:17
Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer
Pfizer's picture
Pfizer
12/07/2017 - 13:00
Estrogen Metabolism in the Lung May Increase Lung Cancer Risk
Fox Chase's picture
Fox Chase
12/07/2017 - 11:14
Purdue professor receives grants to improve gene therapy for cancer
Purdue University's picture
Purdue
12/07/2017 - 10:29
Common Genetic Fusion Event May be Associated with Low-risk Prostate Cancer
American Association for Cancer Research's picture
American Associ...
12/07/2017 - 03:45
Alexion and Halozyme Enter License Agreement for ENHANZE Technology
Halozyme's picture
Halozyme
12/06/2017 - 20:50
Why Do Children Get Cancer?
Roswell Park Cancer Institute's picture
Roswell Park Ca...
12/06/2017 - 17:54
Blood test could predict skin cancer's return
Cancer Research UK's picture
Cancer Research UK
12/06/2017 - 17:47
The new Lucile Packard Childrens Hospital Stanford opens its doors
Stanford Children’s Health's picture
Stanford Childr...
12/06/2017 - 15:47
Rice lab gives structure to histone discovery
Rice University's picture
RiceUniv
12/06/2017 - 10:27
Increasing the Dose Intensity of Chemotherapy May Lower the Risk of Breast Cancer Recurrence and Death
American Association for Cancer Research's picture
American Associ...
12/05/2017 - 17:19
FDA Grants Genentechs Avastin Full Approval for Most Aggressive Form of Brain Cancer
Genentech's picture
Genentech
12/05/2017 - 10:45
Moffitt Cancer Center Uses Innovative Treatment Strategy to Overcome Drug Resistance
Moffitt's picture
Moffitt
12/05/2017 - 08:13
Researchers 3D print lifelike artificial organ models
University of Minnesota's picture
UniversityofMin...
12/05/2017 - 05:45
Shut-off switch for lymphoma
Technical University of Munich's picture
Technical Unive...
12/04/2017 - 21:37
Phase 3 Study Evaluating IMBRUVICA (ibrutinib) in Combination with Rituximab in Waldenstroms Macroglobulinemia Met Primary Endpoint
Johnson and Johnson's picture
Johnson and Johnson
12/04/2017 - 20:49
Dana-Farber/Brigham and Women's Cancer Center launches new program to target aggressive thyroid cancers
Dana Farber's picture
Dana Farber
12/04/2017 - 18:15
A possible workaround for targeting the untargetable in a childhood nerve tumor
Broad Institute's picture
Broad Institute
12/04/2017 - 15:35
Tapping the genome's social network to find cancer drivers
Broad Institute's picture
Broad Institute
12/04/2017 - 07:21
BioLineRx Reports Overall Survival Results from Long-Term Follow-Up of Phase 2a Trial in r/r AML
Biolinerx's picture
Biolinerx
11/30/2017 - 13:24
FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers
Centers for Medicare & Medicaid Services's picture
CMS.gov
11/30/2017 - 12:40
Public resource of cellular effects of drugs and genes boosts drug discovery and offers insights into protein function
Broad Institute's picture
Broad Institute
11/30/2017 - 12:39
Cell atlas of head and neck cancers reveals metastatic mechanisms
Broad Institute's picture
Broad Institute
11/30/2017 - 11:52
Researchers advance technique to detect ovarian cancer
Rice University's picture
RiceUniv
11/30/2017 - 09:59
Study on the interaction of about half of human cancer inhibitors
Technical University of Munich's picture
Technical Unive...
11/30/2017 - 06:57
Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors
Celldex's picture
Celldex
11/30/2017 - 04:37
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Epic Sciences's picture
Epic Sciences
11/29/2017 - 11:10
Urban American-Indian and Alaskan Natives May Have Lower Survival Following Invasive Prostate and Breast Cancer
American Association for Cancer Research's picture
American Associ...
11/28/2017 - 15:54
Does Where You Live Impact Stomach Cancer Risk?
Roswell Park Cancer Institute's picture
Roswell Park Ca...
11/27/2017 - 12:46
Cell death linked to tumor growth in prostate cancer patients
University of Michigan's picture
University of M...
11/24/2017 - 06:19
Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software
Hologic's picture
Hologic
11/24/2017 - 04:59
Study finds colorectal cancer cells and bacteria to be fellow travelers during metastasis
Dana Farber's picture
Dana Farber
11/21/2017 - 14:54
Supplemental Biologics License Application (sBLA) seeks first indication for DARZALEX for the treatment of newly diagnosed patients
Johnson and Johnson's picture
Johnson and Johnson
11/21/2017 - 14:49
Society For Immunotherapy of Cancer (SITC) Spearheads Initiative to Align Management of Immunotherapy Side Effects
Roswell Park Cancer Institute's picture
Roswell Park Ca...
11/21/2017 - 04:11
ArQule Announces Dosing in a Registrational Trial of FGFR Inhibitor, Derazantinib, for Treatment of Intrahepatic Cholangiocarcinoma
ArQule's picture
ArQule
11/21/2017 - 03:16
Immune Checkpoint Inhibitor Atezolizumab Significantly Improves Progression Free Survival in Patients with Non-Small Cell Lung Cancer Compared with Chemotherapy in the IMpower150 Study
Chugai's picture
Chugai
11/20/2017 - 17:29
St. Baldricks Foundation Grants $95,775 to Local Researcher to Fund Lifesaving Childhood Cancer Research
St. Baldrick's Foundation's picture
St. Baldrick's ...
11/20/2017 - 10:13
Cell-weighing method could help doctors choose cancer drugs
Massachusetts Institute of Technology's picture
MIT
11/20/2017 - 08:05
Florida-based Supplement Sellers Settle FTC False Advertising Charges
Federal Trade Commission's picture
FTC
11/20/2017 - 04:54
BioLineRx Announces Partial Results of BL-8040 COMBAT Study Accepted for Presentation at ASCO 2018 Gastrointestinal Cancers Symposium
Biolinerx's picture
Biolinerx